Tag: preclinical
-
Zika Vaccine Clinical Trial Underway
The first of a series of clinical trials testing inactivated Zika particles as a vaccine to protect against the live Zika virus is recruiting participants.
-
Lilly, Institute Partner on Tuberculosis Drug Discovery
Drug maker Eli Lilly and Company is continuing its collaboration with Infectious Disease Research Institute to discovery new drugs that treat tuberculosis.
-
Institutes, Companies Form Business to Bridge Discovery Gap
Three research institutions with pharmaceutical and venture capital companies are creating a new enterprise to fill the drug development gap between proof-of-concept and initial clinical trials.
-
Biotech, Novartis Partner on Rare Metabolic Diseases
A biotechnology start-up enterprise using genome editing for drug discovery is collaborating with drug maker Novartis on rare metabolic disorders.
-
Mobile Multichannel Biomarker Detector Designed
An engineering lab designed a portable testing device connected to a smartphone that can analyze multiple specimen samples for a leading cancer biomarker.
-
Funds Provided for Developing RNA-Based Zika Vaccine
Researchers from Infectious Disease Research Institute, or Idri, are receiving funding from National Institutes of Health to develop a new type of vaccine for the Zika virus.
-
Drug Shown to Improve Cell Energy, Muscle Function
Results of a clinical trial show an experimental drug by Stealth BioTherapeutics boosts cellular energy and improves skeletal muscle functions of older adults.
-
Lung Tissue Grown in Lab from Stem Cells
Researchers in regenerative medicine at UCLA grew three-dimensional pieces of human lung tissue in lab cultures starting from stem cells.
-
Brain Signals Drive Computer Cursor for Faster Typing
A system capturing motor signals in the brain is shown in tests with monkeys to direct a cursor to type text on a keyboard display at rates as high as 12 words per minute.
-
Small Business Grant Funds Flu Therapy R&D
A biotechnology company in South Dakota is developing an influenza therapy, with backing from a National Institutes of Health program supporting research by small enterprises.